219 related articles for article (PubMed ID: 20831190)
1. Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
Verenich S; Gerk PM
Mol Pharm; 2010 Dec; 7(6):2030-9. PubMed ID: 20831190
[TBL] [Abstract][Full Text] [Related]
2. 2-Methoxyestradiol--a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents.
Sutherland TE; Anderson RL; Hughes RA; Altmann E; Schuliga M; Ziogas J; Stewart AG
Drug Discov Today; 2007 Jul; 12(13-14):577-84. PubMed ID: 17631253
[TBL] [Abstract][Full Text] [Related]
3. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors.
Schumacher G; Neuhaus P
J Cancer Res Clin Oncol; 2001 Jul; 127(7):405-10. PubMed ID: 11469676
[TBL] [Abstract][Full Text] [Related]
4. 2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor.
Gorska-Ponikowska M; Perricone U; Kuban-Jankowska A; Lo Bosco G; Barone G
J Cell Physiol; 2017 Nov; 232(11):3030-3049. PubMed ID: 28262924
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug.
Kumar BS; Raghuvanshi DS; Hasanain M; Alam S; Sarkar J; Mitra K; Khan F; Negi AS
Steroids; 2016 Jun; 110():9-34. PubMed ID: 27020471
[TBL] [Abstract][Full Text] [Related]
6. 2-Methoxyestradiol--biology and mechanism of action.
Mueck AO; Seeger H
Steroids; 2010 Oct; 75(10):625-31. PubMed ID: 20214913
[TBL] [Abstract][Full Text] [Related]
7. Advance of 2-methoxyestradiol as a promising anticancer agent for cancer therapy.
Ba M; Duan Y
Future Med Chem; 2020 Feb; 12(4):273-275. PubMed ID: 31983223
[No Abstract] [Full Text] [Related]
8. 2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer.
Sutherland TE; Schuliga M; Harris T; Eckhardt BL; Anderson RL; Quan L; Stewart AG
Clin Cancer Res; 2005 Mar; 11(5):1722-32. PubMed ID: 15755993
[TBL] [Abstract][Full Text] [Related]
9. Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.
Peyrat JF; Brion JD; Alami M
Curr Med Chem; 2012; 19(24):4142-56. PubMed ID: 22709003
[TBL] [Abstract][Full Text] [Related]
10. Novel p-carborane-containing multitarget anticancer agents inspired by the metabolism of 17β-estradiol.
Kaise A; Ohta K; Endo Y
Bioorg Med Chem; 2017 Dec; 25(24):6371-6378. PubMed ID: 29054710
[TBL] [Abstract][Full Text] [Related]
11. Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol.
Gorska M; Wyszkowska RM; Kuban-Jankowska A; Wozniak M
Anticancer Res; 2016 May; 36(5):2217-26. PubMed ID: 27127126
[TBL] [Abstract][Full Text] [Related]
12. SAR studies of 2-methoxyestradiol and development of its analogs as probes of anti-tumor mechanisms.
Ho A; Kim YE; Lee H; Cyrus K; Baek SH; Kim KB
Bioorg Med Chem Lett; 2006 Jul; 16(13):3383-7. PubMed ID: 16650989
[TBL] [Abstract][Full Text] [Related]
13. Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells.
Ghosh R; Ganapathy M; Alworth WL; Chan DC; Kumar AP
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):25-35. PubMed ID: 19084597
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of 2-methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayers.
Wang SH; Shi X; Chen X; Baker JR
Macromol Biosci; 2009 May; 9(5):429-36. PubMed ID: 19370749
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evidence for anti-inflammatory properties of 2-methoxyestradiol.
Shand FH; Langenbach SY; Keenan CR; Ma SP; Wheaton BJ; Schuliga MJ; Ziogas J; Stewart AG
J Pharmacol Exp Ther; 2011 Mar; 336(3):962-72. PubMed ID: 21177477
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M
J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315
[TBL] [Abstract][Full Text] [Related]
17. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
Zhu BT; Conney AH
Cancer Res; 1998 Jun; 58(11):2269-77. PubMed ID: 9622057
[TBL] [Abstract][Full Text] [Related]
18. Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198.
LaVallee TM; Burke PA; Swartz GM; Hamel E; Agoston GE; Shah J; Suwandi L; Hanson AD; Fogler WE; Sidor CF; Treston AM
Mol Cancer Ther; 2008 Jun; 7(6):1472-82. PubMed ID: 18566218
[TBL] [Abstract][Full Text] [Related]
19. The effect of exchanging various substituents at the 2-position of 2-methoxyestradiol on cytotoxicity in human cancer cell cultures and inhibition of tubulin polymerization.
Cushman M; Mohanakrishnan AK; Hollingshead M; Hamel E
J Med Chem; 2002 Oct; 45(21):4748-54. PubMed ID: 12361402
[TBL] [Abstract][Full Text] [Related]
20. Neuronal nitric oxide synthase induction in the antitumorigenic and neurotoxic effects of 2-methoxyestradiol.
Gorska M; Kuban-Jankowska A; Zmijewski MA; Gorzynik M; Szkatula M; Wozniak M
Molecules; 2014 Aug; 19(9):13267-81. PubMed ID: 25170949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
